Daudi Cells
CAD$545.10*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
Essential facts about Daudi cells
| Description | The Daudi cell line was established in 1967 from a 16-year-old African boy diagnosed with Burkitt's Lymphoma, a type of lymphoma. Named after the patient from whom it was derived, the Daudi cell line is characterized by its Epstein-Barr Virus (EBV) positivity, a common feature in Burkitt's lymphoma and several other lymphoproliferative disorders. The EBV infection within these cells offers a unique model for studying the virus's role in tumorigenesis, particularly in the context of B-cell malignancies. Daudi human cells lack expression of the classical Major Histocompatibility Complex (MHC) class I molecules on their surface, which is attributed to the absence of beta-2-microglobulin, a crucial component responsible for the correct intracellular folding and processing of the MHC class I molecule in the endoplasmic reticulum. The lack of beta-2-microglobulin in the Daudi cell line leads to a lack of glycosyl modifications necessary for proper cell surface expression of these molecules. The Daudi cell line is extensively utilized in immunology research, particularly in studies involving the immunodepletion of lymphocyte subpopulations, including lymphocytes, natural killer cells, and peripheral blood mononuclear cells. In summary, the Daudi cell line serves as a critical resource for advancing our knowledge in various research fields, from the basic understanding of cell biology to the development of targeted therapies for cancer treatment. |
|---|---|
| Organism | Human |
| Tissue | Blood |
| Disease | Burkitt lymphoma |
| Applications | Analysis of B cell surface antigens, testing of cytotoxic drugs, mutational analysis, analysis of apoptotic mechanisms, assay development. |
| Synonyms | DAUDI, NK-10A, NK-10a, NK 10a, NK10a, N, GM03190, GM3190, GM03190A, GM17346 |
Details
| Age | 16 years |
|---|---|
| Gender | Male |
| Ethnicity | African |
| Morphology | Round cells |
| Cell type | B lymphoblast |
| Growth properties | Suspension |
Identifiers
| Citation | Daudi (Cytion catalog number 302009) |
|---|---|
| Biosafety level | Daudi cells do not release Epstein-Barr virus (EBV) when cultured, classifying them as Risk Group 1. However, when used for genetic experiments, they should be treated as Risk Group 2 cells. |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_0008 |
Genetics
| Antigen expression | CD10+, CD19+, CD20+, CD21+, CD22+, CD23-, CD24-, CD32+, CD37+, CD38+, CD39-,CD40+, CD54+, CD72+, CD73-, CD75+, CD77+, CD81+, CD82+, CD83-, CD84+, CD86+ |
|---|---|
| Karyotype | 46, almost diploid |
Daudi cell line culturing methods
| Culture Medium | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| Supplements | Supplement the medium with 10% heat-inactivated FBS |
| Subculturing | Maintain cultures by periodically adding or replacing the medium. Initiate cultures with a density of 5 x 105 cells/ml and keep the cell concentration within the range of 3 x 105 to 1 x 106 cells/ml for optimal growth. |
| Seeding density | 3 x 105 cells/ml |
| Fluid renewal | 2 times per week |
| Post-Thaw Recovery | Fast (48 hours) |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality control of Daudi cells
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 302009-140723 | Certificate of Analysis | 23. May. 2025 | 302009 |
| 302009-110425 | Certificate of Analysis | 23. May. 2025 | 302009 |